Players are enhancing and adding newer features to differentiate their product offerings in the fiercely competitive MS market. These not only improve the performance of routine...
The current advancements in medical research, and in the diagnostic capabilities provided by flow cytometric technology provoke a shift in the flow cytometric business landscape. The...
There has been a huge shift from traditional PCRs to real-time over the last three years. With sales at ₹100 crore in 2021, this segment is...
The automation and integration that will transform LC-MS/MS into an integral and cost-effective part of medical diagnostics are technically feasible, as demonstrated by the partial automation...
Coupled with the global healthcare crisis from the pandemic, strengthening India’s pharma sector is now a national security imperative. With the FSSAI stiffening rules, the HPLC...
It is time to look at the DNA sequencing landscape with fresh eyes. For DNA sequencing, this is the year of the big shake-up. From basic biology...
Improvements in HPLC systems are sure to continue, but perhaps not from the direction one would assume. New HPLC systems seem to be more focused on...
“By 2050, the ways in which we watch our health, seek medical advice, get treatment, and what we’re treated for will change dramatically. While it is...
The advantage of automation is that instruments are more powerful, can aggregate data more quickly, and can find analytical insights that otherwise would not be found...
Life sciences companies face distinct challenges with their very visible role in drug pricing and access to medicines, and the pandemic only underscored this focus. Even...
As flow cytometry improved in capability and precision, its applicability to immunologists and cancer researchers grew repidly. However, the best is yet to come! Flow cytometry...
MS is getting bigger and better and is poised to continue to evolve, both in terms of instrumentation and in the range of applications. In clinical...
Instead of being utilized solely for research, less complex tools that rely on cloud computing and AI could change the market. The Covid-19 pandemic underscores a...
The single- and triple-quadrupoles saw traction in 2020 over the other segments. While globally the triple-quadrupoles are increasingly preferred over their single counterparts, India being a...
Sequencing capabilities today are work-in-progress; they are a long way off to where sequencing becomes ubiquitous, comprehensive, and accurate. Forty years ago, the advent of Sanger...
Copyright © 2023 Medical Buyer